AR088678A1 - Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable - Google Patents

Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable

Info

Publication number
AR088678A1
AR088678A1 ARP120104179A ARP120104179A AR088678A1 AR 088678 A1 AR088678 A1 AR 088678A1 AR P120104179 A ARP120104179 A AR P120104179A AR P120104179 A ARP120104179 A AR P120104179A AR 088678 A1 AR088678 A1 AR 088678A1
Authority
AR
Argentina
Prior art keywords
ivabradine
pharmaceutically acceptable
addition salts
acceptable acid
synthesis procedure
Prior art date
Application number
ARP120104179A
Other languages
English (en)
Inventor
Vaysse-Ludot Lucile
Renaud Jean
Luc-Pannetier Nicolas
Lecouve Jean
Pierre-Moulin Solenne
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47115640&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR088678(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR088678A1 publication Critical patent/AR088678A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J35/00—Catalysts, in general, characterised by their form or physical properties
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicación 1: Procedimiento de síntesis de la ivabradina de fórmula (1) caracterizado porque se somete el compuesto de fórmula (2) a una reacción de aminación reductora por la amina de fórmula (3) en presencia de un catalizador a base de hierro, en presencia o no de N-óxido de trimetilamina, bajo una presión de dihidrógeno comprendida entre 1 y 20 bares, en un disolvente orgánico o una mezcla de disolventes orgánicos, a una temperatura comprendida entre 25 y 100ºC.
ARP120104179A 2011-12-20 2012-11-07 Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable AR088678A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1103933A FR2984319B1 (fr) 2011-12-20 2011-12-20 Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Publications (1)

Publication Number Publication Date
AR088678A1 true AR088678A1 (es) 2014-06-25

Family

ID=47115640

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120104179A AR088678A1 (es) 2011-12-20 2012-11-07 Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable

Country Status (35)

Country Link
US (1) US8513410B2 (es)
EP (1) EP2607353B1 (es)
JP (1) JP5670406B2 (es)
KR (1) KR101470879B1 (es)
CN (1) CN103172566B (es)
AR (1) AR088678A1 (es)
AU (1) AU2012244188B2 (es)
BR (1) BR102012028614A2 (es)
CA (1) CA2795741C (es)
CL (1) CL2012003136A1 (es)
CY (1) CY1115682T1 (es)
DK (1) DK2607353T3 (es)
EA (1) EA026510B1 (es)
ES (1) ES2525032T3 (es)
FR (1) FR2984319B1 (es)
GE (1) GEP20156350B (es)
HK (1) HK1186733A1 (es)
HR (1) HRP20141023T1 (es)
JO (1) JO3031B1 (es)
MA (1) MA34276B1 (es)
MD (1) MD4336C1 (es)
MX (1) MX2012012938A (es)
MY (1) MY170662A (es)
PE (1) PE20131097A1 (es)
PL (1) PL2607353T3 (es)
PT (1) PT2607353E (es)
RS (1) RS53541B1 (es)
SA (1) SA112330994B1 (es)
SG (1) SG191471A1 (es)
SI (1) SI2607353T1 (es)
TW (1) TWI440627B (es)
UA (1) UA111329C2 (es)
UY (1) UY34423A (es)
WO (1) WO2013093220A1 (es)
ZA (1) ZA201208160B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN105669554A (zh) * 2016-02-22 2016-06-15 徐建立 一种盐酸伊伐布雷定杂质及其制备方法和应用
FR3071833B1 (fr) * 2017-09-29 2020-01-03 Universite Paris-Sud Nouveau procede de synthese d'amines tertiaires dissymetriques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
US6225487B1 (en) * 1998-04-17 2001-05-01 Symyx Technologies, Inc. Ancillary ligands and metal complexes, catalysts and compositions using same and methods of testing
US6521793B1 (en) * 1998-10-08 2003-02-18 Symyx Technologies, Inc. Catalyst ligands, catalytic metal complexes and processes using same
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
EP1595888A1 (en) * 2004-05-11 2005-11-16 Degussa AG Cycloolefin phosphine ligands and their use in catalysis
ES2381771T3 (es) * 2006-11-30 2012-05-31 Cadila Healthcare Limited Procedimiento para la preparación de hidrocloruro de ivabradina
US7857994B2 (en) 2007-05-30 2010-12-28 GE Lighting Solutions, LLC Green emitting phosphors and blends thereof
RU2473544C2 (ru) * 2007-05-30 2013-01-27 Инд-Свифт Лабораториз Лимитед Способ получения ивабрадина гидрохлорида и его полиморфных модификаций
FR2920773B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2933975B1 (fr) * 2008-07-17 2011-02-18 Servier Lab Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
FR2940287B1 (fr) * 2008-12-24 2010-12-24 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.
FR2941695B1 (fr) * 2009-02-04 2011-02-18 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable

Also Published As

Publication number Publication date
UA111329C2 (uk) 2016-04-25
MD4336C1 (ro) 2015-10-31
NZ603483A (en) 2014-02-28
CN103172566B (zh) 2015-11-18
HK1186733A1 (zh) 2014-03-21
MY170662A (en) 2019-08-26
ZA201208160B (en) 2013-06-26
PL2607353T3 (pl) 2015-01-30
AU2012244188A1 (en) 2013-07-04
HRP20141023T1 (hr) 2014-12-05
WO2013093220A1 (fr) 2013-06-27
CA2795741C (fr) 2015-09-08
JP2013129650A (ja) 2013-07-04
JO3031B1 (ar) 2016-09-05
GEP20156350B (en) 2015-08-25
RS53541B1 (en) 2015-02-27
MX2012012938A (es) 2013-06-19
EP2607353B1 (fr) 2014-08-27
DK2607353T3 (en) 2014-12-08
EP2607353A1 (fr) 2013-06-26
UY34423A (es) 2013-07-31
US8513410B2 (en) 2013-08-20
KR101470879B1 (ko) 2014-12-09
CN103172566A (zh) 2013-06-26
JP5670406B2 (ja) 2015-02-18
CA2795741A1 (fr) 2013-06-20
PE20131097A1 (es) 2013-10-12
EA201201385A1 (ru) 2013-06-28
TW201326132A (zh) 2013-07-01
CY1115682T1 (el) 2017-01-25
SA112330994B1 (ar) 2015-08-03
SI2607353T1 (sl) 2014-12-31
MD4336B1 (ro) 2015-03-31
PT2607353E (pt) 2014-10-10
ES2525032T3 (es) 2014-12-16
EA026510B1 (ru) 2017-04-28
MA34276B1 (fr) 2013-06-01
US20130158256A1 (en) 2013-06-20
SG191471A1 (en) 2013-07-31
CL2012003136A1 (es) 2014-08-01
TWI440627B (zh) 2014-06-11
BR102012028614A2 (pt) 2014-12-16
AU2012244188B2 (en) 2015-07-30
FR2984319B1 (fr) 2013-12-27
KR20130071350A (ko) 2013-06-28
FR2984319A1 (fr) 2013-06-21

Similar Documents

Publication Publication Date Title
AR074845A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
CL2009001414A1 (es) Procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-ona sin aislacion de compuestos intermediarios; util para la sintesis de ivabradina.
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
CL2023000228A1 (es) Procesos para preparar derivados de 3-(2-pirimidinil) pirazoles
UY32499A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
IN2015DN00665A (es)
AR088678A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
CL2012000739A1 (es) Procedimientos de preparacion del acido 2-[(3,5-difluoro-3'-metoxi-1,1'-bifenil-4-il)amino]nicotinico; y uno de los compuestos intermedios considerados.
UY33893A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
GB201104203D0 (en) Chemical process
UY32500A (es) Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
UY35108A (es) Nuevo procedimiento de síntesis del (2e)-3-(3,4-dimetoxifenil) prop-2-enonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
MD20130092A2 (ro) Procedeu nou de sinteză a 3-(2-bromo-4,5-dimetoxifenil)propannitril şi aplicarea în sinteza ivabradinei şi a sărurilor sale de adiţie cu un acid farmaceutic acceptabil
UY35561A (es) Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
AR089325A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
MD4461B1 (ro) Procedeu de sinteză a compuşilor 7,8-dimetoxi-1,3-dihidro-2H-3-benzazepin-2-onei şi aplicarea în sinteza ivabradinei
AR090497A1 (es) Procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
UY35068A (es) Nuevo procedimiento de síntesis del 3-(2-bromo-4,5-dimetoxifenil)propanonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable
TH148556B (th) กระบวนการใหม่สำหรับการสังเคราะห์ของไอวาบราดีน (ivabradine) และ เกลือของมันจากการเติมด้วยกรดที่เป็นที่ยอมรับในทางเภสัชกรรม
TH123120B (th) กระบวนการแบบใหม่ในการสังเคราะห์ไอวาบราดีนและเกลือของสารดังกล่าวเติมด้วยกรดซึ่งเป็นที่ยอมรับทางเภสัชกรรม
PL404511A1 (pl) Aminoester pochodna estru kwasu 2-(2-formylofenoksy)alkanowego oraz sposób jego wytwarzania
MX2012013730A (es) Sintesis por electrocarboxilacion para obtener intermedios utiles para la sintesis de derivados de span.
TH93370B (th) กระบวนการสำหรับการผลิต 1-(3,4-ไดคลอโรเบนซิล)-5-ออคทิลไบกัวไนด์หรือเกลือของสารนี้
GT201300176A (es) Nuevo procedimiento de sintesis de la agomelatina

Legal Events

Date Code Title Description
FB Suspension of granting procedure